11c-sarcosine
Psychoses
Herzog HospitalradiopharmaceuticalPhase 2Dormant
B
62/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 47/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Psychoses cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Lorazepam University of Michigan | Phase 4 | BB |
SERINE D-FORM University of Minnesota | Phase 3 | BB |
Acp-103 ACADIA Pharmaceuticals Inc. | Phase 2 | B |
Daaoi-1 China Medical University Hospital | Phase 2 | B |
Same molecule, other indications
11c-sarcosine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →